|
Resolution: standard / high Figure 1.
Amyloid-β-related mitochondrial impairment. Mitochondria were found to be the target for amyloid-β (Aβ), which interacts with
several proteins, leading to mitochondrial dysfunction. Indeed, Aβ was found in the
outer mitochondrial membrane (OMM) and inner mitochondrial membrane (IMM) as well
as in the matrix. The interaction of Aβ with the OMM affects the transport of nuclear-encoded
mitochondrial proteins, such as subunits of the electron transport chain complex IV,
into the organelle via the translocase of the outer membrane (TOM) import machinery.
Moreover, Aβ disturbs the activity of several enzymes, such as pyruvate dehydrogenase
(PDH) and α-ketoglutarate dehydrogenase (αKGDH), decreasing NADH reduction, and the
electron transport chain enzyme complex IV, reducing the amount of hydrogen that is
translocated from the matrix to the intermembrane space (IMS), thus impairing the
mitochondrial membrane potential (MMP). Taken together, these events cause abnormal
mitochondrial electron activities, leading to decreased complex V activity and so
to a drop in ATP levels, in addition to increasing reactive oxygen species (ROS) generation.
Moreover, ROS induce peroxidation of several mitochondrial macromolecules, such as
mitochondrial DNA (mtDNA) and mitochondrial lipids, contributing to mitochondrial
impairment in the mitochondrial matrix. The complex of Aβ bound to binding alcohol
dehydrogenase (ABAD) impairs the binding of NAD+ to ABAD, changes mitochondrial membrane
permeability and reduces activities of respiratory enzymes, inducing further ROS production
and leading to mitochondrial failure. Aβ binding also activates Fis1 (fission protein)
and promotes increased mitochondrial fragmentation; this increased mitochondrial fragmentation
produces defective mitochondria that ultimately damage neurons. Furthermore, Aβ binding
to cyclophilin D (CypD) enhances the protein translocation to the inner membrane,
favouring the opening of the mitochondrial permeability transition pore, formed by
the adenine nucleotide translocator (ANT) and voltage-dependent anion channels (VDACs).
Cyt C, cytochrome C; DLP1, dynamin-like protein 1; PDH, pyruvate dehydrogenase; ProAp,
proapoptotic factors; SOD, superoxide dismutase; TCA, tricarboxylic acid; TIM, translocase
of the inner membrane.
Eckert et al. Alzheimer's Research & Therapy 2011 3:15 doi:10.1186/alzrt74 |